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Summary
 
Much excitement has arisen from the observation that
decrements in insulin-like signaling can dramatically extend
lifespan in the nematode, 
 
Caenorhabditis elegans
 
, and
fruitfly, 
 
Drosophila melanogaster
 
. In addition, there are
tantalizing hints that the IGF-I pathway in mice may have
similar effects. In addition to dramatic effects on lifespan,
invertebrate insulin-like signaling also promotes changes
in stress resistance, metabolism and development. Which, if
any, of the various phenotypes of insulin pathway mutants
are relevant to longevity? What are the genes that function
in collaboration with insulin to prolong lifespan? These
questions are at the heart of current research in 
 
C. elegans
 
longevity. Two main theories exist as to the mechanism behind
insulin’s effects on invertebrate longevity. One theory is that
insulin programs metabolic parameters that prolong or reduce
lifespan. The other theory is that insulin determines the cell’s
ability to endure oxidative stress from respiration, thereby
determining the rate of aging. However, these mechanisms
are not mutually exclusive and several studies seem to support
a role for both. Here, we review recently published reports
investigating the mechanisms behind insulin’s dramatic
effect on longevity. We also spotlight several 
 
C. elegans
 
genes that are now known to interact with insulin signaling
to determine lifespan. These insights into pathways affecting
invertebrate lifespan may provide a basis for developing
strategies for pharmacological manipulation of human lifespan.
Key words: Aging; 
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phosphoinositol 3-kinase.
 
Introduction
 
Insulin-like signaling has dramatic effects on longevity in several
organisms. Genetic mutations reducing insulin-like signaling
can extend adult lifespan in 
 
Caenorhabditis elegans
 
, 
 
Drosophila
melanogaster
 
 and, possibly, mice (Tatar 
 
et al
 
., 2003; Baba 
 
et al
 
.,
2005). An enticing extension of these findings is that insulin-
like signaling will also affect human longevity. In addition to the
potential for endocrine control of aging by insulin, signaling
through insulin-like pathways is also a major factor in the devel-
opment of cancer and diabetes, both of which have increased
incidence at older ages (Saltiel & Kahn, 2001; Osaki 
 
et al
 
.,
2004). Cellular insulin resistance is a key feature in diabetes mel-
litus, a serious aging-related disease that is increasing with the
growing epidemic of obesity (Vollenweider, 2003). Cancer can
arise when mutations activate signaling downstream of insulin/
IGF-I receptors leading to dysregulated cell growth (Cantley &
Neel, 1999; Lawlor & Alessi, 2001). Thus, the components of
insulin-like signaling pathways are at the center of several
important aspects of aging and longevity. As such, pharmaco-
logical manipulation of this signaling pathway holds significant
promise for improving human health in old age.
Here, we review recent studies that have uncovered new details
about how insulin signaling affects lifespan in the nematode 
 
C.
elegans
 
. We examine the components of the 
 
C. elegans
 
 insulin
pathway and several newly described interacting pathways.
Finally, we will discuss the cellular effects of insulin signaling
that may affect lifespan and discuss opportunities for pharma-
cological intervention highlighted by 
 
C. elegans
 
 biology.
 
The pathways mediating insulin-like signaling 
in 
 
C. elegans
 
 and humans
 
Insulin and IGF-I are peptide hormones that signal through
dimeric receptor tyrosine kinases to activate phosphoinositide
3-kinase (PI3K), resulting in the production of phosphoinositide-
3,4,5-P
 
3
 
  (PI-3,4,5-P
 
3
 
) and phosphoinositide-3,4-P
 
2
 
  (PI-3,4-P
 
2
 
).
Major effectors of the phospholipid products of PI3K are the
serine/threonine kinases, AKT/PKB and PDK-1. PDK-1 phospho-
rylates and activates PIP-bound AKT/PKB, which, in turn, phos-
phorylates downstream target proteins (Fig. 1A). In 
 
C. elegans
 
,
all the components of this signaling pathway are conserved and
function to modulate wild-type longevity, stress resistance and
reproductive development. Mutations in 
 
daf-2
 
, encoding an insulin
receptor-like protein, or 
 
age-1
 
, encoding the catalytic subunit
of PI3K, increase adult longevity and stress resistance and can
cause constitutive developmental arrest as dauer larvae, an
alternative third stage larval form that is optimized for long-term
survival under harsh environmental conditions (Fig. 2) (Kenyon
 
et al
 
., 1993; Malone 
 
et al
 
., 1996; Morris 
 
et al
 
., 1996; Kimura
 
et al
 
., 1997). In addition, LY294002, a chemical inhibitor of PI3 K,
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altered lifespan, stress resistance and dauer formation in
 
C. elegans
 
 (Babar 
 
et al
 
., 1999). Both IST-1, an IRS-like protein,
and AAP-1, a p55-like PI3K adaptor protein, facilitate signaling
between DAF-2/IR and AGE-1/PI3K (Wolkow 
 
et al
 
., 2002). The
phospholipid products of AAP-1/AGE-1 PI3K activate downstream
serine/threonine kinases AKT-1 and PDK-1 (Paradis & Ruvkun,
1998; Paradis 
 
et al
 
., 1999). The serum glucocorticoid kinase,
SGK-1, also transduces signals from PI3K in both mammals and
nematodes (Brunet 
 
et al
 
., 2001; Hertweck 
 
et al
 
., 2004).
In 
 
C. elegans
 
, the major target of insulin-like signaling is the
FOXO transcription factor, DAF-16, whose mammalian orthologs
are FOXO1, FOXO3a and FOXO4 (Lin 
 
et al
 
., 1997; Ogg 
 
et al
 
.,
1997). DAF-2/IR signaling activates AKT-1, which phosphorylates
DAF-16, blocking DAF-16 nuclear entry (Henderson & Johnson,
2001; Lee 
 
et al
 
., 2001; Lin 
 
et al
 
., 2001). When signaling through
the DAF-2 pathway is turned off, AKT-1-mediated inhibition of
DAF-16 is relieved and DAF-16 translocates into the nucleus to
promote target gene expression. It is believed that the direct
transcriptional targets of DAF-16/FOXO are responsible for the
stress resistance and longevity phenotypes associated with
 
daf-2
 
/IR mutations.
Several important studies examining the transcriptome of
 
daf-2(
 
−
 
)
 
 strains have elucidated some tantalizing molecular clues
about the mechanisms for insulin’s effects on longevity. In these
studies, gene expression in long-lived 
 
daf-2(
 
−
 
)
 
 strains was exam-
ined using full-genome microarrays or serial analysis of gene
expression (SAGE) techniques (McElwee 
 
et al
 
., 2003, 2004;
Murphy 
 
et al
 
., 2003; Halaschek-Wiener 
 
et al
 
., 2005). In a com-
plementary study, a biochemically defined DAF-16 binding site
was used to define DAF-16 target genes by computational
methods, focusing on 
 
C. elegans
 
 genes with orthologs in the
Fig. 1 Pathways controlling longevity in collaboration with DAF-16/FOXO in Caenorhabditis elegans. Orange designates genes whose loss-of-function phenotype 
is increased lifespan while blue designates genes whose loss-of-function phenotype is reduced lifespan. (A) Ligands activate the DAF-2/InsR receptor that recruits 
AGE-1/PI3K to the cell membrane. AGE-1/PI3K generates phospholipid signals, PIPs, which activate serine/threonine kinases AKT-1, -2, PDK-1 and SGK-1. These 
kinases phosphorylate DAF-16/FOXO preventing nuclear translocation. DAF-18/PTEN negatively regulates AGE-1 signaling by dephosphorylating PIPs. (B) In 
response to cellular stress, JNK-1 promotes DAF-16 translocation into the nucleus, activating genes to increase stress resistance (Oh et al., 2005). HSF-1 is 
activated by stress and promotes the expression of hsps in collaboration with DAF-16 (Hsu et al., 2003; Morley & Morimoto, 2004). BAR-1/beta-catenin acts 
as a cofactor for DAF-16-mediated expression of antioxidant genes and is required for wild-type lifespan (Essers et al., 2005). (C) Pathways that sense metabolic 
status and prolong lifespan. TOR is a sensor of nutrient availability that coordinates protein synthesis and metabolism in both vertebrates and invertebrates. 
In C. elegans, mutations inactivating TOR, encoded by the let-363 gene, cause developmental arrest and can increase adult lifespan in a daf-16-independent 
manner (Vellai et al., 2003; Jia et al., 2004). daf-15 encodes the RAPTOR subunit for TOR/LET-363 and is transcriptionally repressed by DAF-16/FOXO (Jia et al., 
2004). Metabolic status can also be transduced by the NAD-dependent protein deacetylase, SIR-2.1. Increased sir-2.1 activity increases lifespan in a daf-16-
dependent manner, and DAF-16 may be a substrate for SIR-2.1 deacetylation (Tissenbaum & Guarente, 2001).
Fig. 2 Developmental arrest in the dauer larval stage. Scale bar indicates 100 
microns. (A) A wild-type adult hermaphrodite that is reproductively active and 
laying eggs. Under normal growth conditions, wild-type animals proceed 
through development to become fertile adults. (B) An age-1(mg109) animal 
arrested as a dauer larvae. Dauer larvae are morphologically distinct from 
reproductive adults and are nonreproductive. (C) A sterile age-1(mg109) 
adult. Under semipermissive conditions, some mutant animals can bypass 
dauer arrest, but form sterile, adult-sized animals lacking functional gonads 
(Gottlieb & Ruvkun, 1994). 
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Drosophila
 
  genome and conserved DAF-16 binding sites
(Furuyama 
 
et al
 
., 2000; Lee 
 
et al
 
., 2003). Not surprisingly, given
the high sensitivity of the expression analysis methods, the sets
of affected transcripts did not fully overlap among the studies.
However, similar changes were detected in specific genes, as
pointed out by Halascheck-Wiener 
 
et al
 
. (2005) (Table 1). In
particular, general stress-response genes, such as heat-shock
proteins, were up-regulated in 
 
daf-2(
 
−
 
)
 
 strains, while genes
associated with reproduction and growth, such as vitellogenin
yolk proteins, were down-regulated.
These examinations of the 
 
daf-2(
 
−
 
)
 
  transcriptome showed
clearly that expression of stress-response genes was likely to be
related to increased lifespan in these strains. Indeed, comple-
mentary studies have shown that changes of these genes can
have direct effects on longevity. In particular, overexpression of
 
hsp-16
 
  extended lifespan of wild-type and 
 
age-1(
 
−
 
)
 
  animals
(Walker & Lithgow, 2003). In addition, dsRNA-mediated knock-
down of the genes that were up-regulated in 
 
daf-2(
 
−
 
)
 
 animals
was able to partially suppress the increased longevity phenotype
(Lee 
 
et al
 
., 2003; Murphy 
 
et al
 
., 2003). The gene expression
changes also appear to suggest that long lifespan may result,
in part, from modifying resource allocation. For example, various
DNA and protein metabolism genes were reduced in long-lived
 
daf-2(
 
−
 
)
 
  animals (Table  1). Consistent with this hypothesis,
lifespan of wild-type animals was increased by RNAi-mediated
knockdown of genes down-regulated in 
 
daf-2(
 
−
 
)
 
, suggesting that
those gene activities incurred a cost to survival of the organism
(Murphy 
 
et al
 
., 2003)
Interestingly, transcriptome analyses identified both up- and
down-regulated genes as putative DAF-16 targets and both
types of transcriptional targets contain putative DAF-16 binding
sites in their promoters (Murphy 
 
et al
 
., 2003). It remains to be
determined whether these are all direct DAF-16 target genes
 
in vivo
 
. If all are bona fide targets of DAF-16, this would suggest
that DAF-16 can both increase and decrease gene expression
under similar conditions. Perhaps this dual role is accomplished
via interactions with partner proteins that assemble activator or
repressor complexes at promoters. Alternatively, DAF-16 may
directly affect expression of relatively few target genes that trig-
ger a cascade of downstream gene expression changes. In either
case, it will be exciting to decipher the details of these various
effects.
 
Identification of tissues where DAF-2/insulin 
signaling regulates longevity
 
The cellular effects of insulin and IGF-I in mammals are varied
and complex, due to the fact that both peptides have endocrine,
paracrine and autocrine effects on a variety of tissues. Insulin
is produced mainly by pancreatic beta cells and IGF-I is produced
by a wide variety of cells throughout the body, with hepatic
IGF-I accounting for the majority of circulating bound IGF-I. In
most tissues, insulin and IGF-I binding stimulate cell growth. Cir-
culating glucose can stimulate insulin release, while many factors
promote IGF-I secretion, including pituitary growth hormone
(GH) and muscle contraction. Insulin binding to target cells stim-
ulates glucose uptake and increases glucose metabolism, in part
through effects on gene expression. IGF-I promotes growth and
the absence of the IGF-I signaling system impairs growth during
development (Butler & LeRoith, 2001). Although the liver con-
tributes the majority of bound IGF-I in the circulation, liver-
specific IGF-I knockouts revealed that hepatic IGF-I secretion is
not essential for growth and suggested that growth-promoting
IGF-I can be provided by other tissues (Yakar 
 
et al
 
., 1999). In
addition to these cellular effects, binding of insulin and IGF-I can
affect the release of downstream factors, promoting secondary
effects through the body.
Several recent reports have investigated the cell biological
aspects of DAF-2 signaling in 
 
C. elegans
 
. The 
 
C. elegans
 
 genome
contains 38 
 
ins
 
 genes that encode insulin-like peptides, some
of which have been shown to act as either agonists or antagonists
of the 
 
daf-2
 
 pathway (Pierce 
 
et al
 
., 2001; Hua 
 
et al
 
., 2003; Li
 
et al
 
., 2003). The 
 
C. elegans ins
 
 genes are expressed throughout
the body, with most showing some kind of neuronal expression
(Pierce 
 
et al
 
., 2001). This widespread 
 
ins
 
 expression may indicate
that these peptides can act locally, through paracrine or auto-
crine effects, as opposed to endocrine effects. In 
 
C. elegans
 
,
relatively little is known about the factors that stimulate INS
release. One factor may be from environmental stimuli detected
by sensory neurons, as mutations disrupting sensory neuron
Table 1 Major distinguishing features of the daf-2(−) transcriptome
 
Functional class Transcript (fold-up, -down)
UP in daf-2(− − − −)
Stress resistance hsp-16s and hsp-12s (1.8–253.4*†) (3.4–89‡)
SOD (10.2–17.4‡)
glutathione S-transferase (4–6‡)
Protein synthesis Ribosomal subunit genes (rpl-, rps- genes, 2.4–2.8*†)
Signaling Transthyretin genes (7.1*)
Peptide neurotransmitter-like (8.2*) (3.4–4.1‡)
7-TM receptor (5.1‡)
Protein phosphorylation (3.6‡)
Gene expression tts-1 (21.2–65.3*†)
Collagens col genes (3.6–16.4†)
F02D10.1 (27.8‡)
Metabolism fat-genes (5.1†)
Proteolysis proteases (151–161‡)
DOWN in daf-2(− − − −)
Fertility vitellogenin yolk protein (39.3–385.1*) (17–33‡)
Stress response cey-1, -2, -3 (5.4–15.1*†)
Cell growth Tubulin genes (30.1*)
Actin genes (26.6*)
RNA metabolism (puf genes, 5.8–19.6*†)
DNA metabolism (mcm genes, 15.6–19.4*†)
Protein translation (5.9–28.2*)
Proteolysis asp genes, spp. genes, rpn genes (3.2–8.4*)
cct genes (6.3*)
*Halaschek-Wiener et al. (2005): daf-2(−) vs. daf-2(+), same ‘chronological’ 
age.
†Halaschek-Wiener et al. (2005): daf-2(−) vs. daf-2(+), same ‘biological’ age.
‡McElwee et al. (2003).Insulin signaling in C. elegans, M. S. Gami and C. A. Wolkow
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function can increase lifespan, although INS production has not
been directly examined in these animals (Apfeld & Kenyon,
1999; Alcedo & Kenyon, 2004). The gonad may also contribute
signals promoting INS release. The removal of the germ line,
either through genetic mutation or laser ablation of germ cell
precursors, increases lifespan and this effect appears to occur
via interactions with daf-16/FOXO activity in the intestinal cells
(Arantes-Oliveira et al., 2002; Libina et al., 2003). One possible
mechanism to explain this set of observations is that gonad
signals affect activity of one or several ins genes that bind to
DAF-2 receptors in the intestinal cells.
Binding of INS peptide ligands activates signaling through the
DAF-2 receptor. Several studies have set out to determine
whether DAF-2/DAF-16 signaling promotes wild type lifespan
from specific cells or sets of cells. Mosaic and transgenic analysis
showed that DAF-2 and AGE-1 could function non-cell auto-
nomously from either the nervous system or intestine to promote
wild-type lifespan (Apfeld & Kenyon, 1998; Wolkow et al., 2000).
Since DAF-16 is a direct target of AKT-1, which is downstream
of DAF-2 and AGE-1, it seemed likely that DAF-16 would func-
tion in the same cells as AGE-1 and DAF-2. It was therefore sur-
prising to find that mosaic and transgenic analysis indicated that
daf-16 function in the intestine was necessary for increased
lifespan in daf-2(−) animals, while neuronal daf-16 activity only
promoted dauer arrest (Libina et al., 2003). Taken together, these
reports appear to suggest that DAF-2 signaling need not func-
tion in the same cells as DAF-16/FOXO. In Drosophila, lifespan
was lengthened by overexpressing Drosophila FOXO in fat bodies,
but not neurons, seeming to support the C. elegans results with
daf-16 (Giannakou et al., 2004; Hwangbo et al., 2004).
One possible explanation for the apparent inconsistency in
the cells where DAF-2 and DAF-16 seem to function is that DAF-
2 signaling may affect DAF-16/FOXO both cell autonomously,
through AKT-1 activity, as well as non-cell autonomously, through
downstream pathways. One possible pathway is feedback
regulation via the insulin-like (INS) ligands, which are expressed
throughout the body, provided that the mutant backgrounds
utilized to test this idea could respond, at least partially, to INS
ligands. Alternatively, DAF-2 signaling could impact downstream
pathways that, in turn, transmit DAF-2 signaling throughout the
body. A third possibility is that DAF-16 activity may be regulated
by pathways that function in parallel to AKT-1.
Pathways that interact with insulin signaling 
and control longevity
A new player that is now known to participate in the DAF-16/
FOXO regulation in C. elegans and Drosophila is the Jun N-terminal
kinase (JNK) (Fig. 1B) (Oh et al., 2005; Wang et al., 2005). In
C. elegans, activation of JNK signaling, either by overexpression
or by genetic relief of inhibitory inputs, promoted DAF-16/FOXO
nuclear translocation and increased lifespan. In Drosophila, JNK
activation also mediated feedback inhibition of insulin-like
peptide secretion, further attenuating insulin receptor signaling
(Wang et al., 2005). In C. elegans, a separate p38 MAP kinase,
SEK-1, may also promote DAF-16 nuclear translocation during
oxidative stress (Kondo et al., 2005). These studies indicate that
DAF-16 can be affected by signaling through at least one kinase
cascade apparently independently of DAF-2.
Another gene that can increase lifespan through interactions
with DAF-16 is heat-shock factor-1 (HSF-1) (Fig. 1B) (Hsu et al.,
2003; Morley & Morimoto, 2004). hsf-1 activation by stress pro-
motes expression of inducible heat-shock proteins (hsps). The
observation that hsps are targets of DAF-16 suggested the pos-
sibility that DAF-16 and HSF-1 could collaborate at promoters.
Indeed, sequence and genetic analysis supported this idea. DAF-
16 is also assisted by the β-catenin, BAR-1, which is required for
oxidative stress resistance and expression of antioxidant gene
targets of DAF-16 (Fig. 1B) (Essers et al., 2005).
Nutrient availability affects longevity through two pathways
that interact with the daf-2 pathway (Fig. 1C). The histone
deacetylase, SIRT1, which is a major regulator of the cellular
response to caloric restriction, also modulates the activity of
DAF-16 and promotes longer lifespan (Tissenbaum & Guarente,
2001; Wood et al., 2004). In addition, the mammalian ortholog,
SIRT1, can deacetylate FOXO3a, thereby altering the transcrip-
tional activation of FOXO3a target genes (Brunet et al., 2004;
Motta et al., 2004). As SIRT1 activity is responsive to cellular
metabolic status, the effect of SIRT1 on FOXO activity provides
a way for cellular metabolism to link to FOXO target genes,
which may include stress resistance and metabolism genes, as
they do in C. elegans.
The daf-15 gene, encoding the RAPTOR-like subunit of the
metabolic regulator, TOR, is a downstream target of DAF-16 in
the dauer arrest pathway (Jia et al., 2004). Mutations in daf-15
cause larvae to arrest development as nonrecovering dauer-like
larvae. In addition, adult lifespan was increased in animals with
weak daf-15 mutations that could bypass larval arrest. These
phenotypes are similar to those observed for animals with muta-
tions in CeTOR, encoded by the gene, let-363, indicating that
DAF-15/RAPTOR and CeTOR act together to transduce nutrient
signals (Vellai et al., 2003). Genetic analysis showed that daf-15
likely acts downstream of daf-16 for dauer arrest and daf-16
activity was dispensible for increased lifespan in CeTOR/let363(−)
adults (Fig. 1C) (Vellai et al., 2003). Furthermore, transcriptional
analysis revealed that daf-15  expression was significantly
decreased in long-lived daf-2(e1370) animals (Jia et al., 2004).
These findings show that the TOR nutrient-sensing pathway acts
in parallel, and downstream of, insulin signaling to regulate
larval development and adult longevity.
Another gene that deserves to be noted in this discussion of
interacting pathways is old-1, which encodes a predicted tyro-
sine kinase. old-1  was identified in a screen for genes that
increased longevity when overexpressed, an unusual approach
in C. elegans, where genetic screens are usually performed by
mutating the genome (Murakami & Johnson, 2001). Interestingly,
old-1 mRNA levels were also increased in long-lived daf-2(−)
animals, suggesting this protein may be important for longevity
in these animals (Murphy et al., 2003). Clearly, more remains
to be learned about OLD-1’s role in determining lifespan.Insulin signaling in C. elegans, M. S. Gami and C. A. Wolkow
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Activating mutations in the DAF-2 pathway 
suggest targets for pharmacological 
intervention
The strong developmental phenotypes of mutations inactivating
DAF-2 pathway signaling facilitate genetic identification of
mutations that affect lifespan. In the absence of DAF-2 pathway
signaling, animals constitutively arrest development at the dauer
larval stage. Normally, C. elegans embryos develop through four
larval stages (L1–L4), differing anatomically and by size, before
molting into reproductive adults. First stage (L1) larvae may opt
to enter an alternative third larval stage, called the dauer, in
the presence of environmental conditions that are suboptimal
for reproduction, such as limited nutrients, high population
density or high temperature (Riddle & Albert, 1997). As dauer
larvae, animals can arrest development and survive for several
months until environmental conditions improve. Morphological
features that enhance long-term survival in dauer larvae include
thickening of the cuticle and closure of the bucchal and anal
openings to resist dessication, fat storage for metabolic needs,
and increased expression of antioxidant enzymes, such as SOD
and HSPs (Fig. 2).
Mutations that severely disrupt DAF-2 pathway signaling
cause larvae to arrest development at the dauer larval stage,
regardless of environmental conditions (Gottlieb & Ruvkun,
1994; Malone et al., 1996). In addition, weak decrements in sig-
naling through the DAF-2 pathway can cause animals to develop
into sterile adult-sized animals lacking a functional gonad (Gems
et al., 1998) (Fig. 2). Under some conditions, dauer arrest is a
terminal phenotype and animals cannot recover into reproductive
adults. This feature of the daf-2 pathway mutants suggests that
this pathway also has important functions in dauer recovery.
Developmental arrest of daf-2 pathway mutants facilitates the
straightforward identification of alleles that can activate sign-
aling through this pathway. In these screens, suppressor alleles
are selected that allow daf-2 pathway mutants to bypass dauer
arrest and complete reproductive development. Due to the tight
dauer arrest phenotype of the starting strain, this screening
strategy allows the rapid examination of large numbers of muta-
genized animals for rare reproductive adults.
Screening for suppressors of dauer arrest in age-1(−) animals
led to the identification of activating mutations in the down-
stream kinases, AKT-1 and PDK-1 (Paradis & Ruvkun, 1998;
Paradis et al., 1999). The activating mutation in AKT-1 was an
Ala183Thr mutation in the linker region between the phospholipid-
binding PH domain and the kinase domain (Paradis & Ruvkun,
1998). One scenario for how Ala183Thr activates AKT-1 is by
disrupting autoinhibition of AKT-1 and increasing the basal
activity level of the mutant protein. Although the linker regions
of the human and worm orthologs differ in sequence, they are
likely to carry out similar functions. Thus, it might be possible
to engineer compounds that could mimic the effect of the
Ala183Thr mutation to activate AKT signaling. This type of drug
would be beneficial for treating diseases where AKT activity is
limited, such as for restoring insulin sensitivity in the context of
diabetes mellitus. Indeed LY294002 has been shown to mimic
phenotypes seen in AGE-1/PI3K mutant worms highlighting
how drugs can be useful in pharmacologically manipulating
insulin-like signaling in the worm (Babar et al., 1999). The ease
of screening for suppressors of the daf-2(−) dauer arrest pheno-
type will facilitate the future identification of additional mutations
that activate AKT and PDK-1 kinases.
Concluding remarks
The goal of developing drugs for manipulating lifespan is an
ambitious one. The chances of success in this endeavor will
increase if the proteins that are ultimately the best drug targets
are identified early in the discovery process. Studies of short-
lived invertebrates offer the best possibility to rapidly identify
and characterize pathways that have strong effects on longevity.
Further characterization and validation of these pathways in
mammals will follow with the development of assays for studying
aging within various tissues. The insulin pathway confers the
most dramatic effects to date on longevity in C. elegans and
Drosophila. For this reason, it will be an obvious target for
manipulating longevity in mammals. Furthermore, the importance
of insulin and IGF-I signaling in human diseases, such as diabetes
and cancer, ensure that each new finding will have important
ramifications for human health, notably that of the elderly.
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